Karine Smans

Title: The Innovative Contributions of Karine Smans

Introduction

Karine Smans is a notable inventor based in Beerse, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. Her work focuses on innovative solutions for treating diseases, including cancer.

Latest Patents

Karine Smans holds a patent for an Imidazolin-5-one derivative that serves as a fatty acid synthase (FASN) inhibitor for cancer treatment. This patent discloses compounds, compositions, and methods aimed at addressing various diseases, syndromes, conditions, and disorders. The compounds are particularly effective in inhibiting the FASN enzyme, which is linked to cancer, obesity, and liver-related disorders.

Career Highlights

Karine Smans is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. Her work at Janssen has allowed her to contribute to groundbreaking research and development in the field of medicine. With one patent to her name, she has established herself as an influential figure in her area of expertise.

Collaborations

Throughout her career, Karine has collaborated with esteemed colleagues, including Peter J Connolly and Gilles C Bignan. These collaborations have further enhanced her research and development efforts, leading to innovative solutions in healthcare.

Conclusion

Karine Smans exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in cancer treatment, highlight the importance of research and development in addressing critical health challenges.